Qianmei Wang1, Yuting Duan1,2, Jielin Liang1, Ze Chen1, Juexuan Chen1, Yan Zheng1, Yaolong Chen3,4,5,6, Chunzhi Tang7. 1. Medical College of Acu-Moxi and Rehabilitation, Guangzhou University of Chinese Medicine, No. 232 Waihuan Dong Road, 510000, Guangzhou, China. 2. Hong Kong Chinese Medicine Clinical Study Centre, School of Chinese Medicine, Hong Kong Baptist University, 3/F, Jockey Club School of Chinese Medicine Building, 7 Baptist University Road, Kowloon Tong, Hong Kong SAR, China. 3. Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China. 4. Key Laboratory of Evidence Based Medicine and Knowledge Translation of Gansu Province, Lanzhou, China. 5. Chinese GRADE Center, Lanzhou, China. 6. WHO Collaborating Centre for Guideline Implementation and Knowledge Translation, 199 Donggang West Road, Chengguan District, 730000, Lanzhou, China. 7. Medical College of Acu-Moxi and Rehabilitation, Guangzhou University of Chinese Medicine, No. 232 Waihuan Dong Road, 510000, Guangzhou, China. jordan664@163.com.
Abstract
OBJECTIVE: Reporting Items for Clinical Practice Guidelines (CPGs) in HealThcare (RIGHT) checklist was used as a tool to assess the reporting quality of 2014-2018 CPGs on diabetes treatment, aiming to promote the application of RIGHT and improve the reporting quality of future guidelines. METHODS: We searched Chinese Biomedical Literature Service System (CBM), China National Knowledge Infrastructure (CNKI), Wanfang Data, VIP database, Medline, Embase, Allied, and Complementary MEdicine Database (AMED), and Medlive and Google Scholar (Google academics), and collected published CPGs on diabetes with published date during 1st January, 2014 and 7th November, 2018. CPGs on diabetes issued since 2014 were included and filtered by two reviewers independently. Then the basic information extraction and RIGHT evaluation of the included CPG are carried out. RESULTS: A total of 34 guidelines were included, out of which 7 are for Chinese and 27 for other countries. Overall, basic information (domain 1) got the highest (64.66%) reporting rate, while financing and conflict-of-interest statements and management (domain 6) got the lowest (8.1%). For all guidelines, classification of guidelines (item 1c) was sufficiently reported, and description of the specific sources of funding for all stages of guideline development (item 18a) was not reported. For Chinese CPGs, financing and conflict-of-interest statements and management (domain 6) was most insufficiently reported, and only identification of guideline in the title (item 1a), corresponding information of the developer or author (item 4), description of basic epidemiology (item 5), and subgroup description (item 7b) out of 22 items were better reported than foreign guidelines. CONCLUSIONS: Overall, the CPGs on diabetes during 2014-2018 adhered to ~41% RIGHT checklist, of which Chinese CPGs adhered less than that of foreign guidelines. It is suggested that the RIGHT reporting checklist should be endorsed and used by CPG developers to ensure higher quality and adequate use of guidelines.
OBJECTIVE: Reporting Items for Clinical Practice Guidelines (CPGs) in HealThcare (RIGHT) checklist was used as a tool to assess the reporting quality of 2014-2018 CPGs on diabetes treatment, aiming to promote the application of RIGHT and improve the reporting quality of future guidelines. METHODS: We searched Chinese Biomedical Literature Service System (CBM), China National Knowledge Infrastructure (CNKI), Wanfang Data, VIP database, Medline, Embase, Allied, and Complementary MEdicine Database (AMED), and Medlive and Google Scholar (Google academics), and collected published CPGs on diabetes with published date during 1st January, 2014 and 7th November, 2018. CPGs on diabetes issued since 2014 were included and filtered by two reviewers independently. Then the basic information extraction and RIGHT evaluation of the included CPG are carried out. RESULTS: A total of 34 guidelines were included, out of which 7 are for Chinese and 27 for other countries. Overall, basic information (domain 1) got the highest (64.66%) reporting rate, while financing and conflict-of-interest statements and management (domain 6) got the lowest (8.1%). For all guidelines, classification of guidelines (item 1c) was sufficiently reported, and description of the specific sources of funding for all stages of guideline development (item 18a) was not reported. For Chinese CPGs, financing and conflict-of-interest statements and management (domain 6) was most insufficiently reported, and only identification of guideline in the title (item 1a), corresponding information of the developer or author (item 4), description of basic epidemiology (item 5), and subgroup description (item 7b) out of 22 items were better reported than foreign guidelines. CONCLUSIONS: Overall, the CPGs on diabetes during 2014-2018 adhered to ~41% RIGHT checklist, of which Chinese CPGs adhered less than that of foreign guidelines. It is suggested that the RIGHT reporting checklist should be endorsed and used by CPG developers to ensure higher quality and adequate use of guidelines.
Entities:
Keywords:
RIGHT; clinical practice guidelines; diabetes; reporting quality
Authors: P A Dyson; D Twenefour; C Breen; A Duncan; E Elvin; L Goff; A Hill; P Kalsi; N Marsland; P McArdle; D Mellor; L Oliver; K Watson Journal: Diabet Med Date: 2018-05 Impact factor: 4.359
Authors: Amir Qaseem; Michael J Barry; Linda L Humphrey; Mary Ann Forciea; Nick Fitterman; Carrie Horwitch; Devan Kansagara; Robert M McLean; Timothy J Wilt Journal: Ann Intern Med Date: 2017-01-03 Impact factor: 25.391
Authors: Yaolong Chen; Kehu Yang; Ana Marušic; Amir Qaseem; Joerg J Meerpohl; Signe Flottorp; Elie A Akl; Holger J Schünemann; Edwin S Y Chan; Yngve Falck-Ytter; Faruque Ahmed; Sarah Barber; Chiehfeng Chen; Mingming Zhang; Bin Xu; Jinhui Tian; Fujian Song; Hongcai Shang; Kun Tang; Qi Wang; Susan L Norris Journal: Ann Intern Med Date: 2016-11-22 Impact factor: 25.391
Authors: Sanjay Kalra; Silver Bahendeka; Rakesh Sahay; Sujoy Ghosh; Fariduddin Md; Abbas Orabi; Kaushik Ramaiya; Sameer Al Shammari; Dina Shrestha; Khalid Shaikh; Sachitha Abhayaratna; Pradeep K Shrestha; Aravinthan Mahalingam; Mazen Askheta; Aly Ahmed A Rahim; Fatimah Eliana; Hari K Shrestha; Sandeep Chaudhary; Nancy Ngugi; Jean Claude Mbanya; Than Than Aye; Tint Swe Latt; Zhanay A Akanov; Abbas Raza Syed; Nikhil Tandon; A G Unnikrishnan; S V Madhu; Ali Jawa; Subhankar Chowdhury; Sarita Bajaj; Ashok Kumar Das Journal: Indian J Endocrinol Metab Date: 2018 Jan-Feb
Authors: Jing Han; Meng Tao; Xuan Wu; Ding Li; Yanfang Ma; Shaheenah Dawood; Colin W Steele; Ker-Kan Tan; Qiming Wang Journal: Ann Transl Med Date: 2021-07